Aline Charabaty Pishvaian

Research output

Research output per year 2004 2006 2019 2020 2021 2022 2023 2023

• 44 Article
• 13 Review article
• 7 Comment/debate
• 6 Letter
• 9 More
  • 4 Editorial
  • 3 Short survey
  • 2 Chapter

Research output per year

Research output per year

Search results

• 2023

  @MondayNightIBD and the Expanding Gastroenterology Twitterverse: A Study on Continuing Medical Education on #GITwitter

  Goldowsky, A., Billings, W., Kickel, A. & Charabaty, A., May 1 2023, In: American Journal of Gastroenterology. 118, 5, p. 855-860 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Continuing Medical Education 100%
  • Gastroenterology 84%
  • Psychological Practice 31%
  • Inflammatory Bowel Diseases 28%
  • Social Media 18%

• Editorial: Rectal Urgency Among Patients with Ulcerative Colitis or Crohn’s Disease: Analyses from a Global Survey

  Moon, M., Chowdhury, R. & Charabaty, A., Oct 1 2023, In: Crohn's and Colitis 360. 5, 4, otad054.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

• Parental Leave and Return-to-Work Policies: A Practical Model for Implementation in Gastroenterology

  Feld, L. D., Oxentenko, A. S., Sears, D., Charabaty, A., Rabinowitz, L. G. & Silver, J. K., Oct 2023, In: Gastroenterology. 165, 4, p. 813-818 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Parental Leave and Return-to-Work Policies: A Practical Model for Implementation in Gastroenterology

  Feld, L. D., Oxentenko, A. S., Sears, D., Charabaty, A., Rabinowitz, L. G. & Silver, J. K., Oct 2023, In: Clinical Gastroenterology and Hepatology. 21, 11, p. 2709-2715 7 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

• Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD

  the CORALE-IBD Study Group, Jun 1 2023, In: Inflammatory bowel diseases. 29, 6, p. 883-887 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Inflammatory Bowel Diseases 64%
  • Vaccination 54%
  • Messenger RNA 38%
  • Vaccines 33%

• Structured Medical Education Handles on Twitter: A How-to Guide

  Goldowsky, A., Bilal, M., Kickel, A. & Charabaty, A., Jan 2023, In: Gastroenterology. 164, 1, p. 9-13 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• The Toronto Upper Gastrointestinal Cleaning Score: a prospective validation study

  Khan, R., Gimpaya, N., Vargas, J. I., Ramkissoon, A., Seleq, S., Gholami, R., Akhtar, H. J., Bansal, R., Scaffidi, M. A., Amin, S., Bollipo, S., Kral, J., Lui, R., Pawlak, K. M., Sandhu, D. S., Bilal, M., De-Madaria, E., Siau, K., Charabaty, A., Hashim, A., & 6 othersSánchez-Luna, S. A., Teshima, C. W., May, G. R., Mosko, J. D., Walsh, C. M. & Grover, S. C., Feb 2023, In: Endoscopy. 55, 2, p. 121-128 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Digestive System Endoscopy 100%
  • Validation Studies 83%
  • Prospective Studies 47%
  • Endoscopy 33%
• 2022

  An Overview of the GI Fellowship Interview: Part II—Tips for Selection Committees and Interviewers

  Advani, R., Bollipo, S., Charabaty, A., Duong, N., Bilal, M., Siau, K. & Grover, S. C., May 2022, In: Digestive diseases and sciences. 67, 5, p. 1712-1717 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• An Overview of the GI Fellowship Interview: Part I—Tips for the Interviewee

  Advani, R., Duong, N., Bilal, M., Grover, S. C., Siau, K., Bollipo, S. & Charabaty, A., May 2022, In: Digestive diseases and sciences. 67, 5, p. 1707-1711 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Closing the gender gap: building a successful career and leadership in research as a female gastroenterologist

  Mahadevan, U., Abraham, N. S., Lennon, A. M., Charabaty, A. & Vermeire, S., Jun 2022, In: The Lancet Gastroenterology and Hepatology. 7, 6, p. 501-502 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Closing the gender gap in gastroenterology leadership: the need for effective and comprehensive allyship

  Oxentenko, A., Thomas-Gibson, S. & Charabaty, A., Dec 2022, In: The Lancet Gastroenterology and Hepatology. 7, 12, p. 1070-1072 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Fecal Incontinence and Diarrhea During Pregnancy

  Menees, S. B., Lembo, A. & Charabaty, A., Oct 1 2022, In: American Journal of Gastroenterology. 117, 10 S, p. 26-32 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Identifying and Predicting the Goals and Concerns Prioritised by Individuals with Inflammatory Bowel Disease

  IBD Qorus, Mar 1 2022, In: Journal of Crohn's and Colitis. 16, 3, p. 379-388 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Inflammatory Bowel Diseases 100%
  • Odds Ratio 54%
  • Confidence Intervals 50%
  • Learning Health System 17%
  • Patient Acceptance of Health Care 12%

• Management of Crohn's stricture: Medical, endoscopic and surgical therapies

  Ismail, M. S. & Charabaty, A., Nov 1 2022, In: Frontline Gastroenterology. 13, 6, p. 524-530 7 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Pathologic Constriction 100%
  • Biological Therapy 21%
  • Therapeutics 20%
  • Crohn Disease 17%
  • Endoscopy 16%

• Medical Treatment Options for Ulcerative Colitis

  Sleiman, J., Bassi, M., Tsipotis, E. & Charabaty, A., Nov 2022, In: Clinics in Colon and Rectal Surgery. 35, 6, p. 428-436 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Ulcerative Colitis 100%
  • Cecum 40%
  • Rectum 33%
  • Biological Products 33%
  • Colon 27%

• Recognizing and Managing Irritable Bowel Syndrome in Quiescent Inflammatory Bowel Disease

  Damianos, J. A., Charabaty, A. & Dunleavy, K. A., Apr 2022, In: Practical Gastroenterology. 46, 4, p. 32-49 18 p.

  Research output: Contribution to journal › Article › peer-review

  • Irritable Bowel Syndrome 100%
  • Inflammatory Bowel Diseases 82%
  • Brain Diseases 35%
  • Gastrointestinal Diseases 13%
  • Mental Health 9%

• The present and future of gastroenterology and hepatology: an international SWOT analysis (the GASTROSWOT project)

  de-Madaria, E., Mira, J. J., Carrillo, I., Afif, W., Ang, D., Antelo, M., Bollipo, S., Castells, A., Chahal, P., Heinrich, H., Law, J. K., van Leerdam, M. E., Lens, S., Pannala, R., Park, S. H., Rabiee, A., Savarino, E. V., Singh, V. K., Vargo, J., Charabaty, A., & 1 othersDrenth, J. P. H., May 2022, In: The Lancet Gastroenterology and Hepatology. 7, 5, p. 485-494 10 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Gastroenterology 100%
  • Gastrointestinal Diseases 40%
  • Patient Care 19%
  • Strategic Planning 18%
  • Big Data 17%
• 2021

  Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease

  Pozdnyakova, VALERIYA., Botwin, GREGORY. J., Sobhani, KIMIA., Prostko, J. O. H. N., Braun, JONATHAN., Mcgovern, DERMOT. P. B., Melmed, GIL. Y., Appel, K., Banty, A., Feldman, E., Ha, C., Kumar, R., Lee, S., Rabizadeh, S., Stein, T., Syal, G., Targan, S., Vasiliauskas, E., Ziring, D., Debbas, P., & 30 othersHampton, M., Mengesha, E., Stewart, J. L., Frias, E. C., Cheng, S., Ebinger, J., Figueiredo, J. C., Boland, B., Charabaty, A., Chiorean, M., Cohen, E., Flynn, A., Valentine, J., Fudman, D., Horizon, A., Hou, J., Hwang, C., Lazarev, M., Lum, D., Fausel, R., Reddy, S., Mattar, M., Metwally, M., Ostrov, A., Parekh, N., Raffals, L., Sheibani, S., Siegel, C., Wolf, D. & Younes, Z., Dec 2021, In: Gastroenterology. 161, 6, p. 2041-2043.e1

  Research output: Contribution to journal › Short survey › peer-review

• Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: A two-center observational study

  Zou, F., Faleck, D., Thomas, A., Harris, J., Satish, D., Wang, X., Charabaty, A., Ernstoff, M. S., Glitza Oliva, I. C., Hanauer, S., McQuade, J., Obeid, M., Shah, A., Richards, D. M., Sharon, E., Wolchok, J., Thompson, J. & Wang, Y., Nov 17 2021, In: Journal for immunotherapy of cancer. 9, 11, e003277.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • vedolizumab 100%
  • Infliximab 72%
  • Colitis 63%
  • Diarrhea 51%
  • Observational Studies 48%

• Impact of infliximab therapeutic drug level monitoring on outcomes of patients with inflammatory bowel disease: A real-world experience from a Middle Eastern cohort

  Azzam, N., Aljebreen, A., Alharbi, O., Charabaty, A., Alanazi, M., Alkuwaykibi, N., Alfaraidi, J., Bashamil, A., Almansour, T. & Almadi, M., Mar 2021, In: Arab Journal of Gastroenterology. 22, 1, p. 66-72 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Infliximab 100%
  • Drug Monitoring 98%
  • Inflammatory Bowel Diseases 80%
  • Antibodies 14%
  • Ulcerative Colitis 12%

• Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis

  Alrashed, F., Battat, R., Abdullah, I., Charabaty, A. & Shehab, M., Nov 1 2021, In: BMJ Open Gastroenterology. 8, 1, e000571.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Inflammatory Bowel Diseases 100%
  • Meta-Analysis 79%
  • Systematic Reviews 78%
  • Odds Ratio 68%
  • tofacitinib 61%

• Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients with Superimposed Gastrointestinal Infections

  Ma, W., Gong, Z., Abu-Sbeih, H., Peng, Y., Peng, F., Zou, F., Charabaty, A., Okhuysen, P. C., McQuade, J. L., Altan, M., Zhang, H. C., Thomas, A. S. & Wang, Y., Aug 2021, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 44, 8, p. 402-408 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Colitis 100%
  • Diarrhea 80%
  • Infections 46%
  • Neoplasms 31%
  • Recurrence 13%

• Overcoming imposter syndrome, addressing microaggressions, and defining professional boundaries

  Sears, D., Razeghi, S., Gaidos, J. & Charabaty, A., Nov 2021, In: The Lancet Gastroenterology and Hepatology. 6, 11, p. 881-884 4 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• P033 Moving the Needle on Speaker Diversity at AIBD

  Goldowsky, A., Singh, R., Charabaty, A. & Moss, A. C., Dec 1 2021, In: The American Journal of Gastroenterology. 116, p. S8

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Needles 100%
  • Gastroenterologists 90%
  • Congresses 74%
  • Hispanic Americans 35%
  • Pamphlets 23%

• Social media in inflammatory bowel disease: the patient and physician perspective

  Ahmed, W., Taft, T. H. & Charabaty, A., Jul 1 2021, In: Current opinion in gastroenterology. 37, 4, p. 328-335 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Social Media 100%
  • Inflammatory Bowel Diseases 76%
  • Physicians 51%
  • Pandemics 21%
  • Education 12%

• Standardized reporting of gastroenterology-related social media scholarship for career advancement

  Bilal, M., Aby, E. S., Mahmood, S., Chiang, A. L., Breu, A. C. & Charabaty, A., Aug 2021, In: Nature Reviews Gastroenterology and Hepatology. 18, 8, p. 519-520 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• The Impact of Inflammatory Bowel Disease Related Content Shared on Twitter: Are We Reaching Other Health Care Professionals or Patients?

  Charabaty, A., Jul 1 2021, In: Crohn's and Colitis 360. 3, 3, p. 1-2 2 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access

• Towards meaningful change: the future of gastroenterology belongs to women, diversity, equity, and inclusion

  Matharoo, M. K., Sethi, A. & Charabaty, A., Jul 2021, In: The Lancet Gastroenterology and Hepatology. 6, 7, p. 518-520 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• When burn-out reaches a pandemic level in gastroenterology: A call for a more sustainable work-life balance

  Duong, N., Bollipo, S., Repaka, A., Sebastian, S., Tennyson, C. & Charabaty, A., Sep 1 2021, In: Frontline Gastroenterology. 12, 5, p. 440-443 4 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Young GI angle #Twitter2Paper: Taking an idea from Twitter to paper

  Pawlak, K. M., Siau, K., Bilal, M., Donet, J. A., Charabaty, A. & Bollipo, S., Feb 1 2021, In: United European Gastroenterology Journal. 9, 1, p. 129-132 4 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access
• 2020

  #MondayNightIBD: Management of chronic #Pouchitis

  Donet, J. A., Rieder, F. & Charabaty, A., Oct 1 2020, In: Crohn's and Colitis 360. 2, 4, p. 1-7 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pouchitis 100%
  • Guidelines 43%
  • Consensus 32%
  • Inflammatory Bowel Diseases 31%
  • Inflammation 19%

• Are we ready for proactive therapeutic drug monitoring of Anti-TNF to optimize care of patients with inflammatory bowel disease?

  Charabaty, A., Jan 1 2020, In: Crohn's and Colitis 360. 2, 1

  Research output: Contribution to journal › Editorial › peer-review

  Open Access
  1 Scopus citations

• How to Introduce Scopemanship Into Your Training Program

  Bollipo, S., Bilal, M., Siau, K. & Charabaty, A., Nov 2020, In: Gastroenterology. 159, 5, p. 1648-1652 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  1 Scopus citations

• Impact of COVID-19 on endoscopy trainees: an international survey

  Pawlak, K. M., Kral, J., Khan, R., Amin, S., Bilal, M., Lui, R. N., Sandhu, D. S., Hashim, A., Bollipo, S., Charabaty, A., de-Madaria, E., Rodríguez-Parra, A. F., Sánchez-Luna, S. A., Żorniak, M., Walsh, C. M., Grover, S. C. & Siau, K., Oct 2020, In: Gastrointestinal endoscopy. 92, 4, p. 925-935 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Endoscopy 71%
  • Psychological Burnout 46%
  • Pandemics 42%
  • Anxiety 38%
  34 Scopus citations

• Is the Combination of Pharmacokinetic and Pharmacodynamic Monitoring of Infliximab-Treated Patients the Way Forward?

  Queiroz, N. S. F. & Charabaty, A., Oct 2020, In: Clinical Gastroenterology and Hepatology. 18, 11, p. 2631-2632 2 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• Management of asymptomatic terminal ileitis

  Donet, J. A., Charabaty, A. & Moss, A. C., Oct 1 2020, In: Crohn's and Colitis 360. 2, 4

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Ileitis 100%
  • Colonoscopy 67%
  • Crohn Disease 63%
  • Natural History 33%
  • Intubation 32%

• Response

  Pawlak, K. M., Charabaty, A., Khan, R. & Siau, K., Nov 2020, In: Gastrointestinal endoscopy. 92, 5, p. 1147 1 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• The Impact of COVID-19 on Gastrointestinal Endoscopy Training in the United Kingdom

  EndoTrain Survey Collaborators, Oct 2020, In: Gastroenterology. 159, 4, p. 1582-1585.e3

  Research output: Contribution to journal › Short survey › peer-review
  9 Scopus citations

• The Management Approach to the Adolescent IBD Patient: Health Maintenance and Medication Considerations

  Steinberg, J. M. & Charabaty, A., Jan 1 2020, In: Current gastroenterology reports. 22, 1, 5.

  Research output: Contribution to journal › Review article › peer-review

  • Inflammatory Bowel Diseases 100%
  • Health 51%
  • Vitamin D 28%
  • Iron 25%
  • Transition to Adult Care 23%
• 2019

  A case of checkpoint inhibitor-induced celiac disease

  Alsaadi, D., Shah, N. J., Charabaty, A. & Atkins, M. B., Aug 5 2019, In: Journal for immunotherapy of cancer. 7, 1, 203.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Celiac Disease 100%
  • Nivolumab 41%
  • Mucous Membrane 36%
  • Stomach 32%
  • Undiagnosed Diseases 23%
  3 Scopus citations

• Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis

  Abu-Sbeih, H., Ali, F. S., Wang, X., Mallepally, N., Chen, E., Altan, M., Bresalier, R. S., Charabaty, A., Dadu, R., Jazaeri, A., Lashner, B. & Wang, Y., Apr 2 2019, In: Journal for immunotherapy of cancer. 7, 1, 93.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Colitis 100%
  • Immunosuppressive Agents 81%
  • Steroids 44%
  • Hospitalization 17%
  • Therapeutics 15%
  48 Scopus citations

• Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors

  Rapisuwon, S., Izar, B., Batenchuk, C., Avila, A., Mei, S., Sorger, P., Parks, J. M., Cooper, S. J., Wagner, D., Zeck, J. C., Charabaty, A. J. & Atkins, M. B., Mar 4 2019, In: Journal for immunotherapy of cancer. 7, 1, 61.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Uveomeningoencephalitic Syndrome 100%
  • Central Serous Chorioretinopathy 95%
  • Ipilimumab 93%
  • Nivolumab 90%
  • Vitiligo 84%
  16 Scopus citations

• Immune checkpoint inhibitor-induced colitis: A comprehensive review

  Som, A., Mandaliya, R., Alsaadi, D., Farshidpour, M., Charabaty, A., Malhotra, N. & Mattar, M. C., Feb 1 2019, In: World Journal of Clinical Cases. 7, 4, p. 405-418 14 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • Colitis 100%
  • Infliximab 32%
  • Immunotherapy 24%
  • vedolizumab 22%
  • Steroids 20%
  58 Scopus citations

• Improving immunization strategies in patients with inflammatory bowel disease

  Farshidpour, M., Charabaty, A. & Mattar, M. C., May 3 2019, In: Annals of Gastroenterology. 32, 3, p. 247-256 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Inflammatory Bowel Diseases 100%
  • Immunization 89%
  • Pneumococcal Infections 43%
  • Herpes Zoster 40%
  • Opportunistic Infections 38%
  6 Scopus citations

• Oral vancomycin induces and maintains remission of ulcerative colitis in the subset of patients with associated primary sclerosing cholangitis

  Dao, A., Abidian, M., Lestrange, A., Mattar, M., Rangnekar, A. & Charabaty, A., Jun 18 2019, In: Inflammatory bowel diseases. 25, 7, p. E90-E91

  Research output: Contribution to journal › Letter › peer-review
  4 Scopus citations

• Vedolizumab-induced remission in 3 patients with refractory microscopic colitis: A tertiary care center case series

  Jennings, J. J. & Charabaty, A., Jul 17 2019, In: Inflammatory bowel diseases. 25, 8, p. E97

  Research output: Contribution to journal › Letter › peer-review
  5 Scopus citations
• 2018

  Comparison of propofol versus propofol/fentanyl anesthesia for upper gastrointestinal endoscopy

  Hannallah, M., Carroll, J., Charabaty, A., Palese, C., Barton, F. & Haddad, N., Apr 1 2018, In: Anaesthesia, Pain and Intensive Care. 22, 2, p. 161-164 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Gastrointestinal Endoscopy 100%
  • Fentanyl 90%
  • Propofol 88%
  • Anesthesia 65%
  • Digestive System Endoscopy 36%
  1 Scopus citations

• Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: A multi-center study

  Abu-Sbeih, H., Ali, F. S., Alsaadi, D., Jennings, J., Luo, W., Gong, Z., Richards, D. M., Charabaty, A. & Wang, Y., Dec 5 2018, In: Journal for immunotherapy of cancer. 6, 1, 142.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • vedolizumab 100%
  • Colitis 63%
  • Infliximab 36%
  • Diarrhea 29%
  • Steroids 23%
  53 Scopus citations
• 2017

  MR enterography of inflammatory bowel disease with endoscopic correlation

  Kaushal, P., Somwaru, A. S., Charabaty, A. & Levy, A. D., Jan 1 2017, In: Radiographics. 37, 1, p. 116-131 16 p.

  Research output: Contribution to journal › Article › peer-review

  • Crohn Disease 100%
  • Inflammatory Bowel Diseases 98%
  • Magnetic Resonance Spectroscopy 88%
  • Ulcerative Colitis 82%
  • Endoscopy 37%
  18 Scopus citations

• Stereotactic Body Radiation Therapy (SBRT) Combined with Chemotherapy for Unresected Pancreatic Adenocarcinoma

  Gurka, M. K., Kim, C., He, A. R., Charabaty, A., Haddad, N., Turocy, J., Johnson, L., Jackson, P., Weiner, L. M., Marshall, J. L., Collins, S. P., Pishvaian, M. J. & Unger, K., 2017, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 40, 2, p. 152-157 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Radiosurgery 100%
  • Adenocarcinoma 71%
  • Drug Therapy 53%
  • Pancreatic Neoplasms 38%
  • Radiotherapy 20%
  40 Scopus citations